Health Condition 1: J848- Other specified interstitial pulmonary diseases
Conditions
Interventions
Intervention1: Pulmonary Rehabilitation: Pulmonary Rehabilitation: Pulmonary rehabilitation (PR) program will include breathing retraining, exercise training, education sessions on disease information
Sponsors
Central Council for Research in Yoga and Naturopathy
Eligibility
Inclusion criteria
Inclusion criteria: All participants must have quit smoking at least eight weeks before inclusion into the study. Patients with a clinical diagnosis of moderate to severe interstitial lung disease (ILD) having diagnosis of either Sarcoidosis or Hypersenstivity Pneumonitis (HSP) or Idiopathic Pulmonary Fibrosis (IPF) requiring enrollment into pulmonary rehabilitation program for their disease management.
Exclusion criteria
Exclusion criteria: 1.Patients having co-morbidities likely to affect the study parameters like pulmonary artery hypertension, Obesity hypoventilation, any other concomitant respiratory disease etc. 2.Patients having exercise intolerance due to heart failure, angina pectoris. 3.Endocrinal disorders such as Diabetes mellitus, thyroid disorder that is likely to cause autonomic dysfunction. 4.Patients having episode of acute infection in the month preceding induction into the study or during the study period. 5.Co-morbidities, which make yoga training impossible. 6.Those with complaints of intermittent claudication / varicose veins and Deep Vein Thrombosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Following parameters will be measured after providing Yogic exercises and Pulmonary rehabilitation: 1. Functional exercise capacity and 2. Health Related Quality of Life.Timepoint: Assessment of outcome parameters will be done at time of enrollment and 10 weeks after intervention, which will be either Pulmonary Rehabilitation or Pulmonary Rehabilitation along with specified Yogic exercsies | — |
Secondary
| Measure | Time frame |
|---|---|
| Following parameters will be measured: 1. Pulmonary functions with diffusion. 2. Cardiac autonomic function. 3. Body composition analysis 4. Molecular pathways including inflammatory markers, peripheral Phosphatidylcholine pathways, mitochondrial metabolic pathways, hypoxia response pathways and oxidative balanceTimepoint: Before and after 10 weeks of intervention | — |
Countries
India
Contacts
Public ContactDr Vishal Bansal
V P Chest Institute
Outcome results
None listed